CompaniesCytori Therapeutics

Cytori Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (19)
View all

Total Trials

19

As Lead Sponsor

18

As Collaborator

1

Total Enrollment

485

By Phase

NA: 3PHASE1: 3PHASE2: 4PHASE1/PHASE2: 1PHASE4: 2

By Status

COMPLETED: 10WITHDRAWN: 6NOT_YET_RECRUITING: 1SUSPENDED: 1UNKNOWN: 1
Clinical Trials Pipeline19 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT00426868
NCT00442806
NCT01556022
NCT02732106
NCT02735993
Hover over trial bars to see details

Recent Trials

NCT07117682Lead Sponsor
Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve
NANot yet recruiting
25 participants
Started: Aug 25, 2025 · Completed: Aug 1, 2027
NCT03435172Lead Sponsor
Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds
NASuspended
15 participants
Started: Apr 1, 2018 · Completed: Jul 31, 2021
NCT05797688Collaborator
Adipose-derived Stem Cells to Treat Chronic Wounds.
PHASE1Withdrawn
Started: Dec 31, 2016 · Completed: Sep 30, 2017
NCT02362386Lead Sponsor
Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System
N/ACompleted
17 participants
Started: Jun 30, 2015 · Completed: Feb 29, 2016
NCT02396238Lead Sponsor
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)
NACompleted
88 participants
Started: May 15, 2015 · Completed: May 22, 2018
View all 19 trials →
Funding History (20)
8-K
Aug 26, 2025
Filing
8-K
Aug 14, 2025
Filing
8-K
Aug 14, 2025
Filing
8-K
Aug 13, 2025
Filing
8-K
Aug 12, 2025
Filing
S-1
Aug 12, 2025
Filing
DRS
Aug 4, 2025
Filing
DEFA14A
Aug 1, 2025
Filing
DEF 14A
Jul 21, 2025
Filing
8-K
Jul 18, 2025
Filing